MPO and hepatoblastoma: For instance, in 48 Caucasian children with hepatoblastoma and 180 healthy controls, Pakakasama and colleagues found that a polymorphism (G to A) located in the myeloperoxidase (MPO) gene promoter was associated with decreased hepatoblastoma risk [7].